Glycosylceramide metabolic process

pathway activity — cross-omics
GO:0006677Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Glycosylceramide metabolic process pathway is significantly associated with the RNA expression of multiple genes, with the HNSC cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are MUC1, SPC24, and CDCA2, each associated with the pathway in up to 4 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Glycosylceramide metabolic process activity versus MUC1 in HNSC (Pearson r = 0.05).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
HNSCMUC1 →+1.014+0.195.001<.00134
LSCCSPC24 →-0.828-0.192<.001<.00134
BRCACDCA2 →-0.962-0.177<.001<.00134
BRCAOIP5 →-0.546-0.159<.001<.00134
LSCCMCM4 →-0.839-0.227<.001<.00134
LSCCEZH2 →-0.926-0.215<.001<.00134
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0006677 vs MUC1 — HNSC

Per-sample scatter of Glycosylceramide metabolic process activity vs MUC1 in HNSC.

Explore this scatter interactively →

Exploration